FGF21 plays a critical role in metabolic regulation [45, 46], and its analog has reportedly improved glucose and lipid metabolism and NAFLD in clinical trials [47, 48]. Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.